I
Inhibikase Therapeutics, Inc. (IKT)
NCM – Real Time Price. Currency in USD
1.91
+0.04 (2.14%)
At close: Jun 26, 2026, 4:00 PM EDT
1.92
+0.01 (0.52%)
After-hours: Jun 26, 2026, 5:21 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.91
+0.04 (2.14%)
At close: Jun 26, 2026, 4:00 PM EDT
1.92
+0.01 (0.52%)
After-hours: Jun 26, 2026, 5:21 PM EDT
No Data
There are no news for this stock.
Cash reserves $49.6M barely cover the upcoming debt maturities $0.0
Total current assets $172.2M exceed Total current liabilities $5.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$12.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 30.14 | 6.05 | 10 | |
| Quick ratio | 30.14 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 123K | 261K | N/A | N/A | N/A |
| Gross Profit | 117K | 83K | -26K | -60K | -48K |
| Operating Income | -18M | -20M | -29M | -46M | -56M |
| Net Income | -18M | -19M | -28M | -48M | -51M |
| EBITDA | -18M | -20M | -29M | -46M | -56M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 3.9 | 2.5 |
| Next quarter | N/A | 18.68 | 5.0 |
| Current year | N/A | 14.87 | 4.5 |
| Next year | 33.33 | -5.82 | 5.5 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -28.62 | 0 | -60.44 | 3.3 |
| Y/Y | 999 | -19.74 | 33.33 | -192.92 | 5.5 |
| 3y average | 336.68 | -41.77 | 47.54 | -17.93 | 5.5 |
| 5y average | 251.59 | -113.31 | 4.46 | -248.55 | 4.0 |
| Weighted average score | 4.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |